Identification of a PKP2 gene deletion in a family with arrhythmogenic right ventricular cardiomyopathy

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a primary heart muscle disease characterized by progressive myocardial loss, with fibro-fatty replacement, and high frequency of ventricular arrhythmias that can lead to sudden cardiac death. ARVC is a genetically determined disorder, usually...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of human genetics : EJHG Vol. 21; no. 11; pp. 1226 - 1231
Main Authors Li Mura, Ilena Egle Astrid, Bauce, Barbara, Nava, Andrea, Fanciulli, Manuela, Vazza, Giovanni, Mazzotti, Elisa, Rigato, Ilaria, De Bortoli, Marzia, Beffagna, Giorgia, Lorenzon, Alessandra, Calore, Martina, Dazzo, Emanuela, Nobile, Carlo, Mostacciuolo, Maria Luisa, Corrado, Domenico, Basso, Cristina, Daliento, Luciano, Thiene, Gaetano, Rampazzo, Alessandra
Format Journal Article
LanguageEnglish
Published England Nature Publishing Group 01.11.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a primary heart muscle disease characterized by progressive myocardial loss, with fibro-fatty replacement, and high frequency of ventricular arrhythmias that can lead to sudden cardiac death. ARVC is a genetically determined disorder, usually caused by point mutations in components of the cardiac desmosome. Conventional mutation screening of ARVC genes fails to detect causative mutations in about 50% of index cases, suggesting a further genetic heterogeneity. We performed a genome-wide linkage study and a copy number variations (CNVs) analysis, using high-density SNP arrays, in an ARVC family showing no mutations in any of the desmosomal genes. The CNVs analysis identified a heterozygous deletion of about 122 kb on chromosome 12p11.21, including the entire plakophilin-2 gene and shared by all affected family members. It was not listed on any of available public CNVs databases and was confirmed by quantitative real-time PCR. This is the first SNP array-based genome-wide study leading to the identification of a CNV segregating with the disease phenotype in an ARVC family. This result underscores the importance of performing additional analysis for possible genomic deletions/duplications in ARVC patients without point mutations in known disease genes.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:1018-4813
1476-5438
DOI:10.1038/ejhg.2013.39